Trina Dang

Title: Trina Dang - Innovator in Aldehyde Detection

Introduction

Trina Dang is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of biomedical detection, particularly in the methods and compounds for detecting aldehydes. Her innovative work has the potential to impact various medical conditions, including neurodegenerative disorders and cancer.

Latest Patents

Trina Dang holds a patent for "Methods and compounds for detection and binding of aldehydes." This patent describes methods for detecting an aldehyde-containing compound in a subject or in a sample from a subject. The process involves administering an aldehyde-binding compound of Formula I to the subject or combining it with the sample. The detection of the product can utilize imaging techniques such as MRI, CEST-MRI, or positron emission tomography (PET) imaging. Additionally, fluorescence or electrochemical detection methods may be employed. The biologically relevant aldehydes detected through this method can be used to monitor conditions such as brain injury, Alzheimer's disease, diabetes, heart disease, and cancer.

Career Highlights

Trina is affiliated with the University of Ottawa, where she continues her research and development in the field of biomedical detection. Her work is characterized by a commitment to advancing medical diagnostics and improving patient outcomes.

Collaborations

Trina collaborates with esteemed colleagues, including Adam Shuhendler and Mojmir Suchy, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Trina Dang is a pioneering inventor whose work in aldehyde detection holds promise for significant advancements in medical diagnostics. Her contributions are vital in addressing critical health issues and improving the quality of life for many individuals.